Track topics on Twitter Track topics that are important to you
Firstview Insight's Non Muscle Invasive Bladder Cancer Pipeline Review2019 provides an overview of the pipeline landscape of Non Muscle Invasive Bladder Cancer It provides comprehensive insights of all the clinical and nonclinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the upcoming and existing competitors in their separate therapeutic spaces. The report provides detailed description of the competitor profiles with key milestones and evidence along with analysis by mechanism of action; route of administration; molecule type; stage of development. Information obtained from multiple sources will be used to triangulate and update the profiles. The report also provides key events in the last year related to the indication. This report provides detailed analysis of all the products along with the companies involved.
Nonmuscle invasive bladder cancer NMIBC is cancer found in the tissue that lines the inner surface of the bladder. The bladder muscle is not involved.
Bladder cancer is the 6th most common cancer in the United States. Nearly 81,000 people will be diagnosed in the United States with bladder cancer in 2019. Bladder cancer is more common in males than females. Four times more men than women tend to get this disease.
Bladder cancer is more common as a person grows older. It is found most often in the age group of 7584. More Caucasians than any other ethnicities seem to develop bladder cancer. However, there are more AfricanAmericans who do not survive the disease.The bladder wall has many layers , made up of different types of cells. Most bladder cancers start in the urothelium or transitional epithelium. This is the inside lining of the bladder. Transitional cell carcinoma is cancer that forms in the cells of the urothelium.
Bladder cancer gets worse when it grows into or through other layers of the bladder wall. Over time, the cancer may grow outside the bladder into tissues close by. Bladder cancer may spread to lymph nodes nearby and others farther away. The cancer may reach the bones, the lungs, or the liver and other parts of the body. With NMIBC, the tumor will not have spread outside the bladder.
How do you know that you may have bladder cancer? Some people may have symptoms that suggest they have bladder cancer. Others may feel nothing at all. Some symptoms should never be ignored. You may need to talk to a urologist about your symptoms. A urologist is a doctor who focuses on problems of the urinary system and male reproductive system. Talk to one about:
Hematuria blood in the urine the most common symptom, often without pain
Frequent and urgent urination
Pain when you pass urine
Pain in your lower abdomen
Drug Profile Overview:
The pipeline section provides descriptive drug profiles for the pipeline products including product description, mechanism of action, route of administration, molecule type, technology involved, chemical information.
Clinical Trial Overview:
This section of the report focuses on the clinical activity of the molecule. It includes both clinical and preclinical activity which provides detailed information about the safety, efficacy, tolerability, toxicity of pipeline drugs. A graphical representation of the clinical trial landscape of pipeline therapy which includes information about phase of development, trial design, treatment arms, dosage and frequency, formulation of the drug, primary and secondary completion date, enrolment number, exclusion and inclusion criteria, line of therapy. This section also includes the clinical trial results and analysis based on those results.
Product Development Activity:
This section of the report focuses on detail information about designations, exclusivity details, technology, licensing and collaboration, funding and financing, key milestones and various other development activities.
Company profile includes the detail about type of company, headquarter, global presence, research focus and key financial
The report provides a competitive landscape
The report also provides clinical trial landscape of the pipeline drugs including status; trial phase; sponsor type and endpoint status
The report provides the list of companies which are the most active in the pipeline
The report covers pipeline products based on various stages of development ranging from preregistration till discovery
The report provides descriptive drug profiles which includes product description; comprising detailed mechanism of action MoA; route of administration RoA; Stage of development; clinical trial status; licensing and collaboration details other developmental activities
The report features comparative analysis of product profiles based on molecule type; mechanism of action MoA; route of administration RoA
The report summarizes all the dormant and discontinued pipeline projects
The report also provides latest news for the past one year
Reasons To Buy
To identifying prominent players in the treatment landscape
To determine the drivers; barriers and unmet need in the treatment space
Gain strategically significant competitor information; analysis; and insights to formulate effective RD strategies
Define inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
To understand the composition of the pipeline in terms of molecule type; molecular target; mechanism of action and route of administration
List of productsNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...